Drug Type siRNA |
Synonyms- |
Target |
Action inhibitors |
Mechanism Raf kinase inhibitors(RAF serine/threonine protein kinase inhibitors), RNA interference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | United States | - | |
Head and Neck Neoplasms | Preclinical | - | - |